RBFOX3 and Alzheimer disease: In particular, the expression levels of RBFOX3 encoding neuronal nuclear antigen (NeuN), a marker for post-mitotic neurons, were 18 to 27% lower than non-AD controls, thus supporting the neuronal loss observed in AD cortices.